<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=118459&amp;fmt=gif">
Show all

FDA Approved 55 New Drugs in 2023

medications with FDA approval seal

1 minute read

Fifty-five new treatments were approved by the U.S. Food and Drug Administration (FDA) in 2023. This is a nearly 50% increase from the year before. Typically, 45-50 new drugs are approved each year.Numerous factors, including the complexity of new drugs in development and the advancements in scientific understanding of ailments and their targets, significantly influence the approval of groundbreaking drugs.

High-profile FDA approvals in 2023 include:

  • Alzheimer’s treatment Leqembi
  • Obesity drugs Zepbound and Eisai
  • Gene therapies, including a sickle cell disease treatment


Employer Takeaways

As the FDA ushers in a new era of drug approvals, industry analysts anticipate a surge of breakthroughs in 2024. While the COVID-19 pandemic posed challenges for the FDA's operations, including remote work and delayed inspections, recent data indicates that communication with developers has improved, despite some workflow disruptions and staffing issues.

For employers offering health insurance benefits, it's essential to reassess coverage plans in light of these new drug approvals. Consideration may also be given to incorporating these innovative medications into formularies or adjusting coverage policies. Moreover, these advancements in drug approvals hold the potential for enhanced treatments for various medical conditions, ultimately benefiting employee health and well-being. Download the bulletin for more details.

New call-to-action

National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.

red arrow going upwards over pills
Drug Prices Increasing in January
January 19, 2024
penalty note sitting on desk
2024 Civil Penalty Amounts
January 19, 2024
Nancy Bushard

Nancy Bushard

Nancy Bushard is a firm believer that hard work pays off. True success to her is about providing efficient service and valuable solutions while continually building, refining, and doing the work. Her organized, motivated, and friendly demeanor makes her a great advocate for her customers. As Account Manager for National Insurance Services, Nancy works with schools, cities, and counties in the Midwest Region on their health insurance, wellness plans, benefit communication, and retirement incentives. She oversees new client implementation and meets directly with clients to explain their benefits. Nancy has a strong background in customer service and risk analysis and has been working with employee benefits since 2004. She is a licensed Health and Life insurance agent and is ACA certified.